EUVIMEDEUVIMED entdecken
Crossref

6-Year Overall Survival of Nivolumab Following Stereotactic Ablative Radiotherapy in Early-Stage Non–Small Cell Lung Cancer: Randomized I-SABR Trial

J.Y. Chang, S.H. Lin, W. Dong, Z. Liao, R. Maguire, S. Gandhi, C.M. Gay, J. Zhang, S.G. Chun, Y. Elamin, G.R. Blumenschein, T. Cascone und 8 weitere

International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S39-S40

DOI: 10.1016/j.ijrobp.2026.06.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von J.Y. Chang und 19 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Chang, J., Lin, S., Dong, W., Liao, Z., Maguire, R., Gandhi, S., Gay, C., Zhang, J., Chun, S., Elamin, Y., Blumenschein, G., Cascone, T., Altan, M., Mehran, R., Chen, A., Balter, P., Wu, J., Lee, J., Sharma, P., & Heymach, J. (2026). 6-Year Overall Survival of Nivolumab Following Stereotactic Ablative Radiotherapy in Early-Stage Non–Small Cell Lung Cancer: Randomized I-SABR Trial. International Journal of Radiation Oncology*Biology*Physics, 126(1), S39-S40. https://doi.org/10.1016/j.ijrobp.2026.06.010

Vancouver

Chang J, Lin S, Dong W, Liao Z, Maguire R, Gandhi S, et al. 6-Year Overall Survival of Nivolumab Following Stereotactic Ablative Radiotherapy in Early-Stage Non–Small Cell Lung Cancer: Randomized I-SABR Trial. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S39-S40. doi:10.1016/j.ijrobp.2026.06.010

BibTeX
@article{Chang2026,
  author = {Chang, J.Y. and Lin, S.H. and Dong, W. and Liao, Z. and Maguire, R. and Gandhi, S. and Gay, C.M. and Zhang, J. and Chun, S.G. and Elamin, Y. and Blumenschein, G.R. and Cascone, T. and Altan, M. and Mehran, R. and Chen, A.B. and Balter, P. and Wu, J. and Lee, J.J. and Sharma, P. and Heymach, J.},
  title = {6-Year Overall Survival of Nivolumab Following Stereotactic Ablative Radiotherapy in Early-Stage Non–Small Cell Lung Cancer: Randomized I-SABR Trial},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  volume = {126},
  number = {1},
  pages = {S39--S40},
  doi = {10.1016/j.ijrobp.2026.06.010}
}
Kostenlos starten →